Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 15, 2022

BUY
$2.21 - $3.22 $20,995 - $30,590
9,500 Added 12.23%
87,200 $204,000
Q3 2021

Nov 16, 2021

SELL
$2.8 - $3.72 $396,480 - $526,752
-141,600 Reduced 64.57%
77,700 $242,000
Q2 2021

Aug 16, 2021

BUY
$2.61 - $4.17 $30,798 - $49,206
11,800 Added 5.69%
219,300 $735,000
Q1 2021

May 18, 2021

BUY
$2.91 - $4.32 $357,639 - $530,928
122,900 Added 145.27%
207,500 $645,000
Q4 2020

Feb 17, 2021

SELL
$2.15 - $3.5 $107,715 - $175,350
-50,100 Reduced 37.19%
84,600 $233,000
Q3 2020

Nov 17, 2020

BUY
$2.77 - $6.17 $373,119 - $831,099
134,700 New
134,700 $385,000

Others Institutions Holding VBIV

About VBI Vaccines Inc


  • Ticker VBIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 258,256,992
  • Market Cap $5.17M
  • Description
  • VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...
More about VBIV
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.